急性缺血性卒中血管内治疗入院血压与临床结局及成功再灌注的关系
基于MR CLEAN登记研究3180例接受血管内治疗的患者,入院收缩压和舒张压与90天改良Rankin量表评分及死亡率呈J形关系,拐点分别约150和81 mm Hg。收缩压高于150 mm Hg与不良功能结局和90天死亡率独立相关,且较高收缩压与成功再灌注概率降低及症状性颅内出血发生相关。
要点
- 入院收缩压与90天功能结局及死亡率呈J形关系,拐点约150 mm Hg。
- 收缩压高于150 mm Hg与不良功能结局和90天死亡率独立相关。
- 较高收缩压与成功再灌注概率降低及症状性颅内出血发生相关。
核心结论
- 在急性缺血性卒中接受血管内治疗的患者中,较高的入院血压与成功再灌注概率降低和不良临床结局相关。
- 尚需进一步研究探讨此类患者是否能从血管内治疗前降压治疗中获益。
研究设计与样本
- 研究使用MR CLEAN登记研究数据,为在荷兰常规临床实践中接受血管内治疗的缺血性卒中患者的观察性、前瞻性、全国性队列研究。
- 主要结局为90天改良Rankin量表评分,次要结局包括成功再灌注(扩展脑梗死溶栓评分2B-3)、症状性颅内出血和90天死亡率。
- 采用多变量逻辑回归和线性回归评估收缩压、舒张压与结局的关联,并检验非线性关系,参数估计按血压每升高或降低10 mm Hg计算。
主要发现
- 入院收缩压和舒张压与90天改良Rankin量表评分及死亡率的关系呈J形,拐点分别约150和81 mm Hg。
- 收缩压高于150 mm Hg与不良功能结局相关(校正共同比值比1.09,95%CI 1.04-1.15)。
- 收缩压高于150 mm Hg与90天死亡率相关(校正比值比1.09,95%CI 1.03-1.16)。
- 按线性关系,较高收缩压与成功再灌注概率降低相关(校正比值比0.97,95%CI 0.94-0.99)。
- 较高收缩压与症状性颅内出血发生相关(校正比值比1.06,95%CI 0.99-1.13),舒张压结果与收缩压基本相似。
临床怎么用
- 对于接受血管内治疗的急性缺血性卒中患者,入院时收缩压高于150 mm Hg提示再灌注成功概率较低且临床结局较差。
- 入院血压可作为血管内治疗前风险分层和预后评估的参考指标。
- 血管内治疗前是否应降压治疗尚不明确,需进一步研究验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Optimal blood pressure (BP) targets before endovascular treatment (EVT) for acute ischemic stroke are unknown. We aimed to assess the relation between admission BP and clinical outcomes and successful reperfusion after EVT. METHODS: We used data from the MR CLEAN (Multicenter Randomized Controlled Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry, an observational, prospective, nationwide cohort study of patients with ischemic stroke treated with EVT in routine clinical practice in the Netherlands. Baseline systolic BP (SBP) and diastolic BP (DBP) were recorded on admission. The primary outcome was the score on the modified Rankin Scale at 90 days. Secondary outcomes included successful reperfusion (extended Thrombolysis in Cerebral Infarction score 2B-3), symptomatic intracranial hemorrhage, and 90-day mortality. Multivariable logistic and linear regression were used to assess the associations of SBP and DBP with outcomes. The relations between BPs and outcomes were tested for nonlinearity. Parameter estimates were calculated per 10 mm Hg increase or decrease in BP. RESULTS: We included 3180 patients treated with EVT between March 2014 and November 2017. The relations between admission SBP and DBP with 90-day modified Rankin Scale scores and mortality were J-shaped, with inflection points around 150 and 81 mm Hg, respectively. An increase in SBP above 150 mm Hg was associated with poor functional outcome (adjusted common odds ratio, 1.09 [95% CI, 1.04-1.15]) and mortality at 90 days (adjusted odds ratio, 1.09 [95% CI, 1.03-1.16]). Following linear relationships, higher SBP was associated with a lower probability of successful reperfusion (adjusted odds ratio, 0.97 [95% CI, 0.94-0.99]) and with the occurrence of symptomatic intracranial hemorrhage (adjusted odds ratio, 1.06 [95% CI, 0.99-1.13]). Results for DBP were largely similar. CONCLUSIONS: In patients with acute ischemic stroke treated with EVT, higher admission BP is associated with lower probability of successful reperfusion and with poor clinical outcomes. Further research is needed to investigate whether these patients benefit from BP reduction before EVT.
引用
- van den Berg SA, Uniken Venema SM, Mulder MJHL, et al. Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment. Stroke. 2020. PMID: 33040702. doi:10.1161/STROKEAHA.120.029907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。